INSERM U1016, Institut Cochin, Faculte de Medecine Cochin Port Royal, 24 rue du Faubourg Saint Jacques, Paris, France.
Blood. 2013 Aug 8;122(6):885-92. doi: 10.1182/blood-2012-11-427765. Epub 2013 May 15.
Although earlier, seminal studies demonstrated that the gut per se has the intrinsic ability to regulate the rates of iron absorption, the spotlight in the past decade has been placed on the systemic regulation of iron homeostasis by the hepatic hormone hepcidin and the molecular mechanisms that regulate its expression. Recently, however, attention has returned to the gut based on the finding that hypoxia inducible factor-2 (HIF-2α) regulates the expression of key genes that contribute to iron absorption. Here we review the current understanding of the molecular mechanisms that regulate iron homeostasis in the gut by focusing on the role of HIF-2 under physiological steady-state conditions and in the pathogenesis of iron-related diseases. We also discuss implications for adapting HIF-2-based therapeutic strategies in iron-related pathological conditions.
尽管早期的开创性研究表明肠道本身具有内在的能力来调节铁吸收的速率,但在过去十年中,人们的注意力集中在肝脏激素铁调素对铁稳态的系统调节及其调节铁调素表达的分子机制上。然而,最近人们又重新关注肠道,因为发现缺氧诱导因子-2(HIF-2α)调节参与铁吸收的关键基因的表达。本文综述了目前对肠道铁稳态调节的分子机制的理解,重点介绍了 HIF-2 在生理稳态条件下和铁相关疾病发病机制中的作用。我们还讨论了在铁相关病理条件下适应基于 HIF-2 的治疗策略的意义。